Safety & Efficacy of Extended Longevity Protocol

Inclusion Criteria:

• 8 Men and 7 Women
• Must between 55-75 years old
• Patient must be able to comply with treatment plan and laboratory tests
• Patients must have adequate immune system function, with no known immunodeficiencydisease

Exclusion Criteria:

• Neoplastic cancer within 5 years prior to screening, except for cutaneous basal cellor squamous cell cancer resolved by excision
• No immune system issues or immunodeficiency disease
• No history of viral illness which could be reactivated by immune downregulation
• Presence of clinically significant acute or unstable cardiovascular andcerebrovascular (stroke) disease
• Diagnosis of a transient ischemic attack in the 6 months prior to screening
• Patients infected with hepatitis, C or HIV
• Patients with Body Mass Index (BMI) > 40 kg/m2
• Presence of active infection
• Any other illness, psychiatric disorder, alcohol or chemical dependence that in theopinion of the investigator would render a patient unsuitable to participate in thestudy
• Unable or unwilling to provide required blood sample for testing